Literature DB >> 10643214

Improvement in severe insulin resistance with frequent injections of lispro insulin.

C H Raine1, M J Krzyston, M Amr, L Hydrick.   

Abstract

Extreme insulin resistance is common in obese African Americans with type 2 diabetes. This case report describes an obese African-American woman who was treated with subcutaneous injections of lispro insulin every 2 hours with resultant decrease of mean daily blood glucose from 264.7 mg/dL to 111 mg/dL and in insulin requirement from 479 U/24 hours to 60 U/24 hours. This case demonstrates that extreme insulin resistance is reversible in the short term.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10643214      PMCID: PMC2608473     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  12 in total

1.  Development of an isotope dilution assay for precise determination of insulin, C-peptide, and proinsulin levels in non-diabetic and type II diabetic individuals with comparison to immunoassay.

Authors:  A D Kippen; F Cerini; L Vadas; R Stöcklin; L Vu; R E Offord; K Rose
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

Review 2.  Glucose toxicity.

Authors:  H Yki-Järvinen
Journal:  Endocr Rev       Date:  1992-08       Impact factor: 19.871

3.  Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells.

Authors:  Z Ling; R Kiekens; T Mahler; F C Schuit; M Pipeleers-Marichal; A Sener; G Kloppel; W J Malaisse; D G Pipeleers
Journal:  Diabetes       Date:  1996-12       Impact factor: 9.461

4.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

Authors:  J H Warram; B C Martin; A S Krolewski; J S Soeldner; C R Kahn
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

5.  Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance.

Authors:  W K Ward; E C LaCava; T L Paquette; J C Beard; B J Wallum; D Porte
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

6.  Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

Authors:  H Ilkova; B Glaser; A Tunçkale; N Bagriaçik; E Cerasi
Journal:  Diabetes Care       Date:  1997-09       Impact factor: 19.112

7.  Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography.

Authors:  D Ostrega; K Polonsky; D Nagi; J Yudkin; L J Cox; P M Clark; C N Hales
Journal:  Diabetes       Date:  1995-04       Impact factor: 9.461

8.  [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin.

Authors:  D C Howey; R R Bowsher; R L Brunelle; J R Woodworth
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

9.  Fast reversibility of glucose-induced desensitization in rat pancreatic islets. Evidence for an involvement of ionic fluxes.

Authors:  M Anello; A M Rabuazzo; C Degano; V Caltabiano; G Patanè; R Vigneri; F Purrello
Journal:  Diabetes       Date:  1996-04       Impact factor: 9.461

10.  Effects of dietary treatment on serum insulin and proinsulin response in newly diagnosed NIDDM.

Authors:  N Yoshioka; T Kuzuya; A Matsuda; Y Iwamoto
Journal:  Diabetes       Date:  1989-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.